Literature DB >> 18854393

Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age.

David M Robertson1, Georgina E Hale, Damien Jolley, Ian S Fraser, Claude L Hughes, Henry G Burger.   

Abstract

CONTEXT: Ovarian hormones regulate pituitary gonadotropin secretion across the menstrual cycle via negative and positive feedback mechanisms. The contribution of individual hormones is complex and is a continuing area of research.
OBJECTIVE: The aim of the study was to identify relationships between LH/FSH and estradiol, progesterone, inhibin A, inhibin B, and anti-Mullerian hormone (AMH) in ovulatory menstrual cycles across reproductive age.
DESIGN: Serum ovarian and pituitary hormones were studied in a group of young (<35 yr; n = 21) and older (>45 yr; n = 55) women. The slopes of the regression lines relating the ovarian and pituitary hormones were determined by multiple linear regression analysis and expressed with 95% confidence intervals for each ovarian hormone, with FSH and LH as independent variables. Both simultaneous and delayed (time lagged) relationships were examined.
RESULTS: Clear associations were evident for the lagged prediction of FSH, with significant negative associations being evident with inhibin B and AMH in the follicular phase and with estradiol, inhibin B, progesterone, and AMH in the luteal phase. For the lagged prediction of LH, significant positive and negative associations were observed with estradiol and inhibin B, respectively, in the follicular phase and a negative association with progesterone and inhibin B in the luteal phase.
CONCLUSIONS: It is concluded that in the follicular phase, inhibin B is a major feedback regulator of FSH and may also be a negative feedback regulator of LH. AMH may be indirectly involved in FSH regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854393     DOI: 10.1210/jc.2008-1684

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  J Clin Endocrinol Metab       Date:  2012-02-16       Impact factor: 5.958

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

3.  Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A.

Authors:  A L Lukefahr; J B Frye; L E Wright; S L Marion; P B Hoyer; J L Funk
Journal:  Calcif Tissue Int       Date:  2012-01-17       Impact factor: 4.333

4.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Fertil Steril       Date:  2012-02-16       Impact factor: 7.329

5.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Menopause       Date:  2012-04       Impact factor: 2.953

6.  Cistanches Herba aqueous extract affecting serum BGP and TRAP and bone marrow Smad1 mRNA, Smad5 mRNA, TGF-β1 mRNA and TIEG1 mRNA expression levels in osteoporosis disease.

Authors:  Hai-Dong Liang; Fang Yu; Zhi-Hong Tong; Hong-Quan Zhang; Wu Liang
Journal:  Mol Biol Rep       Date:  2012-12-12       Impact factor: 2.316

7.  Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period.

Authors:  John F Randolph; Huiyong Zheng; MaryFran R Sowers; Carolyn Crandall; Sybil Crawford; Ellen B Gold; Marike Vuga
Journal:  J Clin Endocrinol Metab       Date:  2010-12-15       Impact factor: 5.958

8.  A factor analysis approach to examining relationships among ovarian steroid concentrations, gonadotrophin concentrations and menstrual cycle length characteristics in healthy, cycling women.

Authors:  E S Barrett; I Thune; S F Lipson; A-S Furberg; P T Ellison
Journal:  Hum Reprod       Date:  2012-12-18       Impact factor: 6.918

9.  Progesterone and bone: actions promoting bone health in women.

Authors:  Vanadin Seifert-Klauss; Jerilynn C Prior
Journal:  J Osteoporos       Date:  2010-10-31

10.  Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging.

Authors:  Siobán D Harlow; Margery Gass; Janet E Hall; Roger Lobo; Pauline Maki; Robert W Rebar; Sherry Sherman; Patrick M Sluss; Tobie J de Villiers
Journal:  Climacteric       Date:  2012-02-16       Impact factor: 3.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.